HER2-Positive Breast Cancer Immunotherapy: A Focus on Vaccine Development
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s00005-019-00566-1.pdf
Reference154 articles.
1. Aboud-Pirak E, Hurwitz E, Pirak ME et al (1988) Efficacy of antibodies to epidermal growth factor receptor against KB carcinoma in vitro and in nude mice. J Natl Cancer Inst 80:1605–1611
2. Al-Awadhi A, Lee Murray J, Ibrahim NK (2018) Developing anti-HER 2 vaccines: B reast cancer experience. Int J Cancer 143:2126–2132
3. Alexe G, Dalgin GS, Scanfeld D et al (2007) High expression of lymphocyte-associated genes in node-negative HER2 + breast cancers correlates with lower recurrence rates. Cancer Res 67:10669–10676
4. Alsaab HO, Sau S, Alzhrani R et al (2017) PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol 8:561
5. Alving CR (1991) Liposomes as carriers of antigens and adjuvants. J Immunol Methods 140:1–13
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Metformin improved a heterologous prime-boost of dual-targeting cancer vaccines to inhibit tumor growth in a melanoma mouse model;International Immunopharmacology;2024-02
2. Recent progress in cancer immunotherapy: Application of nano-therapeutic systems;Journal of Drug Delivery Science and Technology;2024-01
3. GLS and GOT2 as prognostic biomarkers associated with dendritic cell and immunotherapy response in breast cancer;Heliyon;2024-01
4. Design, synthesis and bioactivity evaluation of novel fusion peptides and their CPT conjugates inducing effective anti-tumor responses on HER2 positive tumors;European Journal of Medicinal Chemistry;2024-01
5. A potential cure for tumor‐associated immunosuppression by Toxoplasma gondii;Cancer Reports;2023-12-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3